Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients—A Narrative Review
Beta-lactam antibiotics remain one of the most preferred groups of antibiotics in critical care due to their excellent safety profiles and their activity against a wide spectrum of pathogens. The cornerstone of appropriate therapy with beta-lactams is to achieve an adequate plasmatic concentration o...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-03-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/12/3/568 |
| _version_ | 1797613830426066944 |
|---|---|
| author | Jan Stašek Filip Keller Veronika Kočí Jozef Klučka Eva Klabusayová Ondřej Wiewiorka Zuzana Strašilová Miroslava Beňovská Markéta Škardová Jan Maláska |
| author_facet | Jan Stašek Filip Keller Veronika Kočí Jozef Klučka Eva Klabusayová Ondřej Wiewiorka Zuzana Strašilová Miroslava Beňovská Markéta Škardová Jan Maláska |
| author_sort | Jan Stašek |
| collection | DOAJ |
| description | Beta-lactam antibiotics remain one of the most preferred groups of antibiotics in critical care due to their excellent safety profiles and their activity against a wide spectrum of pathogens. The cornerstone of appropriate therapy with beta-lactams is to achieve an adequate plasmatic concentration of a given antibiotic, which is derived primarily from the minimum inhibitory concentration (MIC) of the specific pathogen. In a critically ill patient, the plasmatic levels of drugs could be affected by many significant changes in the patient’s physiology, such as hypoalbuminemia, endothelial dysfunction with the leakage of intravascular fluid into interstitial space and acute kidney injury. Predicting antibiotic concentration from models based on non-critically ill populations may be misleading. Therapeutic drug monitoring (TDM) has been shown to be effective in achieving adequate concentrations of many drugs, including beta-lactam antibiotics. Reliable methods, such as high-performance liquid chromatography, provide the accurate testing of a wide range of beta-lactam antibiotics. Long turnaround times remain the main drawback limiting their widespread use, although progress has been made recently in the implementation of different novel methods of antibiotic testing. However, whether the TDM approach can effectively improve clinically relevant patient outcomes must be proved in future clinical trials. |
| first_indexed | 2024-03-11T07:01:11Z |
| format | Article |
| id | doaj.art-1751e502d09c4fe38df94ee9c4cc9383 |
| institution | Directory Open Access Journal |
| issn | 2079-6382 |
| language | English |
| last_indexed | 2024-03-11T07:01:11Z |
| publishDate | 2023-03-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Antibiotics |
| spelling | doaj.art-1751e502d09c4fe38df94ee9c4cc93832023-11-17T09:14:53ZengMDPI AGAntibiotics2079-63822023-03-0112356810.3390/antibiotics12030568Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients—A Narrative ReviewJan Stašek0Filip Keller1Veronika Kočí2Jozef Klučka3Eva Klabusayová4Ondřej Wiewiorka5Zuzana Strašilová6Miroslava Beňovská7Markéta Škardová8Jan Maláska9Department of Internal Medicine and Cardiology, Faculty of Medicine, University Hospital Brno, Masaryk University, 625 00 Brno, Czech RepublicDepartment of Anaesthesiology and Intensive Care Medicine, Faculty of Medicine, University Hospital Brno, Masaryk University, 625 00 Brno, Czech RepublicDepartment of Anaesthesiology and Intensive Care Medicine, Faculty of Medicine, University Hospital Brno, Masaryk University, 625 00 Brno, Czech RepublicDepartment of Simulation Medicine, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech RepublicDepartment of Simulation Medicine, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech RepublicDepartment of Laboratory Medicine, Division of Clinical Biochemistry, University Hospital Brno, 625 00 Brno, Czech RepublicDepartment of Laboratory Medicine, Division of Clinical Biochemistry, University Hospital Brno, 625 00 Brno, Czech RepublicDepartment of Laboratory Medicine, Division of Clinical Biochemistry, University Hospital Brno, 625 00 Brno, Czech RepublicDepartment of Clinical Pharmacy, Hospital Pharmacy, University Hospital Brno, 625 00 Brno, Czech RepublicDepartment of Simulation Medicine, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech RepublicBeta-lactam antibiotics remain one of the most preferred groups of antibiotics in critical care due to their excellent safety profiles and their activity against a wide spectrum of pathogens. The cornerstone of appropriate therapy with beta-lactams is to achieve an adequate plasmatic concentration of a given antibiotic, which is derived primarily from the minimum inhibitory concentration (MIC) of the specific pathogen. In a critically ill patient, the plasmatic levels of drugs could be affected by many significant changes in the patient’s physiology, such as hypoalbuminemia, endothelial dysfunction with the leakage of intravascular fluid into interstitial space and acute kidney injury. Predicting antibiotic concentration from models based on non-critically ill populations may be misleading. Therapeutic drug monitoring (TDM) has been shown to be effective in achieving adequate concentrations of many drugs, including beta-lactam antibiotics. Reliable methods, such as high-performance liquid chromatography, provide the accurate testing of a wide range of beta-lactam antibiotics. Long turnaround times remain the main drawback limiting their widespread use, although progress has been made recently in the implementation of different novel methods of antibiotic testing. However, whether the TDM approach can effectively improve clinically relevant patient outcomes must be proved in future clinical trials.https://www.mdpi.com/2079-6382/12/3/568beta-lactam antibioticspharmacokinetics–pharmacodynamicscritically illbacterial susceptibilitytherapeutic drug monitoringhigh-performance liquid chromatography |
| spellingShingle | Jan Stašek Filip Keller Veronika Kočí Jozef Klučka Eva Klabusayová Ondřej Wiewiorka Zuzana Strašilová Miroslava Beňovská Markéta Škardová Jan Maláska Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients—A Narrative Review Antibiotics beta-lactam antibiotics pharmacokinetics–pharmacodynamics critically ill bacterial susceptibility therapeutic drug monitoring high-performance liquid chromatography |
| title | Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients—A Narrative Review |
| title_full | Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients—A Narrative Review |
| title_fullStr | Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients—A Narrative Review |
| title_full_unstemmed | Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients—A Narrative Review |
| title_short | Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients—A Narrative Review |
| title_sort | update on therapeutic drug monitoring of beta lactam antibiotics in critically ill patients a narrative review |
| topic | beta-lactam antibiotics pharmacokinetics–pharmacodynamics critically ill bacterial susceptibility therapeutic drug monitoring high-performance liquid chromatography |
| url | https://www.mdpi.com/2079-6382/12/3/568 |
| work_keys_str_mv | AT janstasek updateontherapeuticdrugmonitoringofbetalactamantibioticsincriticallyillpatientsanarrativereview AT filipkeller updateontherapeuticdrugmonitoringofbetalactamantibioticsincriticallyillpatientsanarrativereview AT veronikakoci updateontherapeuticdrugmonitoringofbetalactamantibioticsincriticallyillpatientsanarrativereview AT jozefklucka updateontherapeuticdrugmonitoringofbetalactamantibioticsincriticallyillpatientsanarrativereview AT evaklabusayova updateontherapeuticdrugmonitoringofbetalactamantibioticsincriticallyillpatientsanarrativereview AT ondrejwiewiorka updateontherapeuticdrugmonitoringofbetalactamantibioticsincriticallyillpatientsanarrativereview AT zuzanastrasilova updateontherapeuticdrugmonitoringofbetalactamantibioticsincriticallyillpatientsanarrativereview AT miroslavabenovska updateontherapeuticdrugmonitoringofbetalactamantibioticsincriticallyillpatientsanarrativereview AT marketaskardova updateontherapeuticdrugmonitoringofbetalactamantibioticsincriticallyillpatientsanarrativereview AT janmalaska updateontherapeuticdrugmonitoringofbetalactamantibioticsincriticallyillpatientsanarrativereview |